Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy
Open Access
- 17 September 2012
- journal article
- review article
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2012, 1-10
- https://doi.org/10.1155/2012/629452
Abstract
The global prevalence of diabetes is estimated to be 336 million people, with diabetic complications contributing to significant worldwide morbidity and mortality. Diabetic retinopathy results from cumulative microvascular damage to the retina and inflammation is recognized as a critical driver of this disease process. This paper outlines the pathophysiology leading to proliferative diabetic retinopathy and highlights many of the inflammatory, angiogenic, and cytokine mediators implicated in the development and progression of this disease. We focus a detailed discussion on the current targeted therapeutic interventions used to treat diabetic retinopathy.Keywords
This publication has 88 references indexed in Scilit:
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030Diabetes Research and Clinical Practice, 2011
- A Potential Role for Angiopoietin 2 in the Regulation of the Blood–Retinal Barrier in Diabetic RetinopathyInvestigative Ophthalmology & Visual Science, 2011
- Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studiesEye, 2011
- Effects of Medical Therapies on Retinopathy Progression in Type 2 DiabetesThe New England Journal of Medicine, 2010
- Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathyNature Medicine, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- VEGF as a Target for NeuroprotectionEpilepsy Currents, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Ranibizumab for Neovascular Age-Related Macular DegenerationThe New England Journal of Medicine, 2006
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004